This presentation will allow the participant to use the foundational tools presented in the first presentation to build on their skill set through clinical exercises to incorporate their understanding of prescribing laws, best practice guidelines and tools to help them to prescribe opioids in such a manner as to mitigate opioid harm as well as avoid opioid use disorders. Further, the participant will be exposed to clinical examples in the literature to build a toolbox to mitigate opioid harm and recognize opioid misuse and abuse.
For Florida podiatrists, no more than 8 hours (20% of the hours of continuing education required per biennium) of home study programs may be credited toward the licensee’s biennial continuing education requirement for license renewal. A test must be completed and passed demonstrating competency in the topic taught in order to receive credit for the course.
Completion (Credits: 1.5) CME (Credits: 1.25)
Complete the 4 steps to earn your CE/CME credit:
This lecture has been approved for the PRESENT Podiatric Education Online curriculum by the Council of Teaching Hospitals Residency Education Review Committee.
Release Date: 02/09/2021 Expiration Date: 12/31/2023
PRESENT e-Learning Systems is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. PRESENT e-Learning Systems has approved this activity for a maximum of 1.25 continuing education contact hours
Release Date: 02/09/2021 Expiration Date: 12/31/2022
To view Lectures online, the following specs are required:
It is the policy of PRESENT e-Learning Systems and it's accreditors to insure balance, independence, objectivity and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any PRESENT e-Learning Systems sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts.---
Robert Smith has nothing to disclose.